Factors Associated with the Risk of Adenoma Recurrence in Distal and Proximal Colon

Background/Aims: Colonoscopy may be less effective in preventing cancer in the proximal colon. We evaluated whether risk factors for adenoma recurrence exhibit differential effect on adenoma recurrence by colon subsite. Methods: We examined the association of age, sex, body mass index, smoking status and use of nonsteroidal anti-inflammatory drugs (NSAIDs) on proximal and distal adenoma recurrence among 1,864 participants in the Polyp Prevention Trial. We used multinomial logistic regression models to calculate the relative risk ratios (RRR) and 95% CI. Results: 733 (39.3%) participants had adenoma recurrence (228 distal only, 369 proximal only and 136 synchronous proximal and distal adenoma). When compared to participants without adenoma recurrence, no factor was associated with an increased risk of distal only adenoma recurrence. Age 65-69 years (RRR = 1.47, 95% CI 1.00-2.16), age ≥70 years (RRR = 2.24, 95% CI 1.57-3.20), and male sex (RRR = 1.73, 95% CI 1.32-2.27) were positively associated with proximal only adenoma recurrence. NSAIDs use was associated with a reduced risk of adenoma recurrence by similar magnitude in distal (RRR = 0.78, 95% CI 0.58-1.07) and proximal colon (RRR = 0.77, 95% CI 0.60-1.00). Conclusions: We did not find any modifiable risk factor that differentially increases proximal as compared to distal adenoma recurrence to be clinically useful for targeted intervention.

[1]  Chyke A Doubeni,et al.  Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. , 2011, Gastrointestinal endoscopy.

[2]  H. Brenner,et al.  Protection From Colorectal Cancer After Colonoscopy , 2011, Annals of Internal Medicine.

[3]  E. Kliewer,et al.  The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. , 2010, Gastroenterology.

[4]  H. Brenner,et al.  Protection from colorectal cancer after colonoscopy: Population-based case-control study , 2010 .

[5]  Chyke A Doubeni,et al.  Socioeconomic and Racial Patterns of Colorectal Cancer Screening among Medicare Enrollees in 2000 to 2005 , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[6]  E. Jacobs,et al.  Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. , 2009, American journal of epidemiology.

[7]  L. Rabeneck,et al.  Association of Colonoscopy and Death From Colorectal Cancer , 2009, Annals of Internal Medicine.

[8]  L. Rabeneck,et al.  Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  S. Kakar,et al.  Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics. , 2008, European journal of cancer.

[10]  D. Rex,et al.  Considerations regarding the present and future roles of colonoscopy in colorectal cancer prevention. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  M. Ferracin,et al.  The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile , 2008, The Journal of pathology.

[12]  P. Albert,et al.  Postpolypectomy Colonoscopy Surveillance Guidelines: Predictive Accuracy for Advanced Adenoma at 4 Years , 2008, Annals of Internal Medicine.

[13]  D. Moher,et al.  Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force , 2007, Annals of Internal Medicine.

[14]  J. Baron,et al.  A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. , 2006, Gastroenterology.

[15]  S. Solomon,et al.  Celecoxib for the prevention of sporadic colorectal adenomas. , 2006, The New England journal of medicine.

[16]  S. Solomon,et al.  Celecoxib for the prevention of colorectal adenomatous polyps. , 2006, The New England journal of medicine.

[17]  Harminder Singh,et al.  Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. , 2006, JAMA.

[18]  J. Meyerhardt,et al.  Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. , 2005, JAMA.

[19]  Sujha Subramanian,et al.  Use of Colonoscopy for Colorectal Cancer Screening: Evidence from the 2000 National Health Interview Survey , 2005, Cancer Epidemiology Biomarkers & Prevention.

[20]  R. Roetzheim,et al.  Predictors of proximalvs. distal colorectal cancers , 2001, Diseases of the colon and rectum.

[21]  J. Weissfeld,et al.  Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. , 2000, The New England journal of medicine.

[22]  W. Ray,et al.  Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. , 1999, Archives of internal medicine.

[23]  S. Freels,et al.  The relation of age, race, and gender to the subsite location of colorectal carcinoma , 1997, Cancer.

[24]  J. Weissfeld,et al.  The polyp prevention trial II: dietary intervention program and participant baseline dietary characteristics. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  A. Schatzkin,et al.  The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  J. Weissfeld,et al.  Erratum: The polyp prevention trial II: Dietary intervention program and participant baseline dietary characteristics (Cancer Epidemiology, Biomarkers and Prevention (May 1996) (385-392)) , 1996 .